학술논문
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged >6 Years with Cystic Fibrosis and at Least One F508del Allele A Phase 3, Open-Label Clinical Trial
Document Type
Article
Author
Source
In: American Journal of Respiratory and Critical Care Medicine . (American Journal of Respiratory and Critical Care Medicine, 1 July 2023, 208(1):68-78)
Subject
Language
English
ISSN
15354970
1073449X
1073449X